328 results
Page 5 of 17
PRER14A
9bs1u5c
27 Oct 20
Preliminary revised proxy
4:14pm
PREC14A
3ovui
21 Oct 20
Preliminary proxy with contested solicitation
5:14pm
8-K
EX-10.1
b6l6rf3s x1ouj
1 Jul 20
Departure of Directors or Certain Officers
8:00am
8-K
00333ax sjo
29 May 20
Ziopharm Oncology Presents Encouraging Clinical Data for ControlledIL-12 for the Treatment of Recurrent Glioblastoma
8:16am
8-K
EX-10.1
vajhhcwjev2o7f z7
29 May 20
Ziopharm Oncology Presents Encouraging Clinical Data for ControlledIL-12 for the Treatment of Recurrent Glioblastoma
8:16am
8-K
EX-10.2
sjydersxykhqbpnxa l5
29 May 20
Ziopharm Oncology Presents Encouraging Clinical Data for ControlledIL-12 for the Treatment of Recurrent Glioblastoma
8:16am
8-K
EX-99.1
a3s w3qhl6toc6y6na5
29 May 20
Ziopharm Oncology Presents Encouraging Clinical Data for ControlledIL-12 for the Treatment of Recurrent Glioblastoma
8:16am
S-8
EX-99.3
3fv1l
8 May 20
Registration of securities for employees
12:00am
8-K
EX-1.1
ctvrehk885wr5sxr
6 Feb 20
Ziopharm Oncology Announces Pricing of Public Offering of Common Stock
9:21am
424B5
ebqozm 05
5 Feb 20
Prospectus supplement for primary offering
5:21pm
424B5
whj0h0q
4 Feb 20
Prospectus supplement for primary offering
5:30pm
8-K
EX-99.1
xuqy09zx7wrehtd
25 Nov 19
Ziopharm Oncology Presents Encouraging Clinical Data for ControlledIL-12 for the Treatment of Recurrent Glioblastoma
9:00am